ARTICLE | Company News
Triplex Pharmaceutical Corp. other research news
May 23, 1994 7:00 AM UTC
The Woodlands, Texas, company received a $70,000 Phase I SBIR from the National Institute of Allergy and Infectious Diseases to determine the feasibility of using nucleic acids to inhibit the integrat...